腹主动脉瘤腔内修复术后急性肾损伤与肾功能下降的决定因素
该队列研究纳入212例择期EVAR患者,评估急性肾损伤(AKI)和慢性肾病(CKD)的危险因素。AKI发生率为15%,血管紧张素II受体阻滞剂使用和围手术期并发症是独立危险因素,他汀类药物为保护因素。EVAR组CKD发生率显著高于对照组(23.5% vs 6.7%,p<.001),主动脉颈直径、肾动脉狭窄>50%和AKI是CKD的预测因素。
要点
- EVAR术后AKI发生率为15%,血管紧张素II受体阻滞剂使用和围手术期并发症增加AKI风险。
- 他汀类药物使用与AKI风险降低相关(OR 0.19)。
- EVAR术后CKD发生率显著高于未手术的较小动脉瘤患者(23.5% vs 6.7%)。
核心结论
- 血管紧张素II受体阻滞剂使用和围手术期并发症是EVAR术后AKI的独立危险因素。
- EVAR术后肾功能下降问题突出,高危患者需长期保护措施。
研究设计与样本
- 连续纳入212例2009年1月至2016年10月择期EVAR的腹主动脉瘤患者。
- 其中149例随访2年的患者与135例未手术的较小动脉瘤患者(心血管风险相似)比较CKD。
主要发现
- AKI发生在30例患者(15%)。
- 多因素分析:血管紧张素II受体阻滞剂(OR 4.08,95%CI 1.38-12.07)和围手术期并发症(OR 3.12,95%CI 1.20-8.10)为AKI独立危险因素。
- 他汀类药物为保护因素(OR 0.19,95%CI 0.07-0.52)。
- EVAR组CKD发生率23.5%,对照组6.7%(p<.001)。
- Cox回归显示主动脉颈直径(每增加1mm,HR 1.13,95%CI 1.02-1.25)、肾动脉狭窄>50%(HR 2.24,95%CI 1.05-4.79)和AKI发生(HR 2.19,95%CI 0.99-4.85)是CKD的显著预测因素。
关键数值与推荐
- AKI采用急性肾损伤网络(AKIN)标准定义。
- CKD采用估算肾小球滤过率根据KDIGO指南评估。
临床怎么用
- 对EVAR患者应评估血管紧张素II受体阻滞剂使用和围手术期并发症等AKI风险。
- 他汀类药物可能具有肾脏保护作用。
- 高危患者(如主动脉颈直径较大、肾动脉狭窄>50%)需长期监测肾功能并采取保护措施。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE/BACKGROUND: Endovascular aneurysm repair (EVAR) may be associated with renal injury and more insight is needed into potential risk factors. The aim was to identify clinical, anatomical, and peri-procedural parameters as potential risk factors for the occurrence of acute kidney injury (AKI) and to evaluate chronic kidney disease (CKD) after EVAR. METHODS: A cohort of 212 consecutive patients who underwent elective EVAR for abdominal aortic aneurysm from January 2009 to October 2016 was included. A subgroup of 149 patients with 2 years follow-up was compared with a set of 135 non-operated aneurysm patients with smaller aneurysms (similar cardiovascular risk profile) to assess CKD. Primary outcomes were AKI (Acute Kidney Injury Network criteria) and CKD measured by estimated glomerular filtration rate (Kidney Disease Improving Global Outcomes guidelines). For AKI, candidate risk factors were identified by univariate and multivariate logistic regression analysis; for chronic renal function decline, risk factors were identified using Cox regression analysis. RESULTS: AKI occurred in 30 patients (15%). On multivariate analysis, the use of angiotensin II blocker (odds ratio [OR] 4.08, 95% confidence interval [CI] 1.38-12.07) and peri-operative complications (OR 3.12, 95% CI 1.20-8.10) were independent risk factors for AKI, whereas statin use was a protective factor (OR 0.19, 95% CI 0.07-0.52). EVAR resulted in a significant increase (23.5%) in the occurrence of CKD compared with the control group (6.7%; p <.001). On univariate and multivariate Cox regression the risk factors: aortic neck diameter (per mm increase) (hazard ratio [HR] 1.13, 95% CI 1.02-1.25), renal artery stenosis >50% (HR 2.24, 95% CI 1.05-4.79), and the occurrence of AKI (HR 2.19, 95% CI 0.99-4.85) were significant predictors of CKD. CONCLUSION: This study identified use of angiotensin II blockers and peri-operative complications as risk factors for AKI. In addition, the problem of renal function decline after EVAR is highlighted, which indicates that prolonged protective measures (e.g., in those patients at high risk) over time are needed to improve patient outcomes.
引用
- Statius van Eps RG, Nemeth B, Mairuhu RTA, et al. Determinants of Acute Kidney Injury and Renal Function Decline After Endovascular Abdominal Aortic Aneurysm Repair. Eur J Vasc Endovasc Surg. 2017. PMID: 29110930. doi:10.1016/j.ejvs.2017.09.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。